TrialOrphanet journal of rare diseases2015

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study.

Ole B Suhr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.